World

Top 946 largest Companies in the Biotechnology industry in the World by Market Cap

This is the list of the largest public listed companies in the Biotechnology industry in the world by market capitalization with links to their reference stock.

World Biotechnology Industry Analysis
World Top Companies World Companies Analysis

Top 1-year algo backtest: +327.04%

$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Top Biotechnology Companies in the World as of Jan. 01, 2025

Rank Company Market Cap (USD) Country Sector Industry
1 Novo Nordisk A/S $622.07 B

(July 1, 2024)

 Denmark Danish Healthcare Danish Biotechnology
2 Vertex Pharmaceuticals Incorporated $113.24 B United States US Healthcare US Biotechnology
3 CSL Limited $95.75 B

(July 1, 2024)

 Australia Australian Healthcare Australian Biotechnology
4 Regeneron Pharmaceuticals, Inc. $76.33 B United States US Healthcare US Biotechnology
5 Marinomed Biotech AG $56.13 B Austria Austria Healthcare Austria Biotechnology
6 Samsung Biologics Co.,Ltd. $49.14 B South Korea South Korean Healthcare South Korean Biotechnology
7 Seagen Inc. $43.15 B

(Dec. 1, 2023)

 United States US Healthcare US Biotechnology
8 argenx SE $39.00 B Netherlands Dutch Healthcare Dutch Biotechnology
9 UCB SA $37.76 B Belgium Belgian Healthcare Belgian Biotechnology
10 Alnylam Pharmaceuticals, Inc. $35.54 B United States US Healthcare US Biotechnology
11 BioNTech SE $28.17 B Germany German Healthcare German Biotechnology
12 BeiGene Ltd $22.69 B China Chinese Healthcare Chinese Biotechnology
13 Viela Bio, Inc. $20.91 B United States US Healthcare US Biotechnology
14 Open Orphan plc $18.70 B United Kingdom UK Healthcare UK Biotechnology
15 Summit Therapeutics Inc. $18.18 B United States US Healthcare US Biotechnology
16 Royalty Pharma plc $18.17 B United States US Healthcare US Biotechnology
17 United Therapeutics Corporation $16.60 B United States US Healthcare US Biotechnology
18 Moderna, Inc. $16.31 B United States US Healthcare US Biotechnology
19 Genmab A/S $15.88 B

(July 1, 2024)

 Denmark Danish Healthcare Danish Biotechnology
20 Neurocrine Biosciences, Inc. $14.94 B United States US Healthcare US Biotechnology
21 Incyte Corporation $13.97 B United States US Healthcare US Biotechnology
22 Insmed Incorporated $13.93 B United States US Healthcare US Biotechnology
23 Intra-Cellular Therapies, Inc. $13.50 B United States US Healthcare US Biotechnology
24 Bio-Techne Corporation $12.22 B United States US Healthcare US Biotechnology
25 Karuna Therapeutics, Inc. $11.94 B

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
26 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd $11.87 B China Chinese Healthcare Chinese Biotechnology
27 BioMarin Pharmaceutical Inc. $11.85 B United States US Healthcare US Biotechnology
28 Sarepta Therapeutics, Inc. $11.38 B United States US Healthcare US Biotechnology
29 Vaxcyte, Inc. $10.63 B United States US Healthcare US Biotechnology
30 Acceleron Pharma Inc. $10.56 B

(Nov. 1, 2021)

 United States US Healthcare US Biotechnology

Top Biotechnology Companies in the World as of Jan. 01, 2025

1. Novo Nordisk

Company Profile: Novo Nordisk A/S
Market Cap (USD): $622.07 B (July 1, 2024)
Country: Denmark
Sector: Danish Healthcare
Industry: Danish Biotechnology

2. Vertex Pharmaceuticals Incorporated

Company Profile: Vertex Pharmaceuticals Incorporated
Market Cap (USD): $113.24 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

3. CSL Limited

Company Profile: CSL Limited
Market Cap (USD): $95.75 B (July 1, 2024)
Country: Australia
Sector: Australian Healthcare
Industry: Australian Biotechnology

4. Regeneron Pharmaceuticals, Inc.

Company Profile: Regeneron Pharmaceuticals, Inc.
Market Cap (USD): $76.33 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

5. Marinomed Biotech AG

Company Profile: Marinomed Biotech AG
Market Cap (USD): $56.13 B
Country: Austria
Sector: Austria Healthcare
Industry: Austria Biotechnology

6. Samsung Biologics Co.,Ltd.

Company Profile: Samsung Biologics Co.,Ltd.
Market Cap (USD): $49.14 B
Country: South Korea
Sector: South Korean Healthcare
Industry: South Korean Biotechnology

7. Seagen Inc.

Company Profile: Seagen Inc.
Market Cap (USD): $43.15 B (Dec. 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

8. argenx SE

Company Profile: argenx SE
Market Cap (USD): $39.00 B
Country: Netherlands
Sector: Dutch Healthcare
Industry: Dutch Biotechnology

9. UCB SA

Company Profile: UCB SA
Market Cap (USD): $37.76 B
Country: Belgium
Sector: Belgian Healthcare
Industry: Belgian Biotechnology

10. Alnylam Pharmaceuticals, Inc.

Company Profile: Alnylam Pharmaceuticals, Inc.
Market Cap (USD): $35.54 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

11. BioNTech SE

Company Profile: BioNTech SE
Market Cap (USD): $28.17 B
Country: Germany
Sector: German Healthcare
Industry: German Biotechnology

12. BeiGene Ltd

Company Profile: BeiGene Ltd
Market Cap (USD): $22.69 B
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

13. Viela Bio, Inc.

Company Profile: Viela Bio, Inc.
Market Cap (USD): $20.91 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

14. Open Orphan plc

Company Profile: Open Orphan plc
Market Cap (USD): $18.70 B
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Biotechnology

15. Summit Therapeutics Inc.

Company Profile: Summit Therapeutics Inc.
Market Cap (USD): $18.18 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

16. Royalty Pharma plc

Company Profile: Royalty Pharma plc
Market Cap (USD): $18.17 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

17. United Therapeutics Corporation

Company Profile: United Therapeutics Corporation
Market Cap (USD): $16.60 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

18. Moderna, Inc.

Company Profile: Moderna, Inc.
Market Cap (USD): $16.31 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

19. Genmab A/S

Company Profile: Genmab A/S
Market Cap (USD): $15.88 B (July 1, 2024)
Country: Denmark
Sector: Danish Healthcare
Industry: Danish Biotechnology

20. Neurocrine Biosciences, Inc.

Company Profile: Neurocrine Biosciences, Inc.
Market Cap (USD): $14.94 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

21. Incyte Corporation

Company Profile: Incyte Corporation
Market Cap (USD): $13.97 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

22. Insmed Incorporated

Company Profile: Insmed Incorporated
Market Cap (USD): $13.93 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

23. Intra-Cellular Therapies, Inc.

Company Profile: Intra-Cellular Therapies, Inc.
Market Cap (USD): $13.50 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

24. Bio-Techne Corporation

Company Profile: Bio-Techne Corporation
Market Cap (USD): $12.22 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

25. Karuna Therapeutics, Inc.

Company Profile: Karuna Therapeutics, Inc.
Market Cap (USD): $11.94 B (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

26. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd

Company Profile: Beijing Wantai Biological Pharmacy Enterprise Co. Ltd
Market Cap (USD): $11.87 B
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

27. BioMarin Pharmaceutical Inc.

Company Profile: BioMarin Pharmaceutical Inc.
Market Cap (USD): $11.85 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

28. Sarepta Therapeutics, Inc.

Company Profile: Sarepta Therapeutics, Inc.
Market Cap (USD): $11.38 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

29. Vaxcyte, Inc.

Company Profile: Vaxcyte, Inc.
Market Cap (USD): $10.63 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

30. Acceleron Pharma Inc.

Company Profile: Acceleron Pharma Inc.
Market Cap (USD): $10.56 B (Nov. 1, 2021)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

Top 1-year algo backtest: +327.04% - Try Disfold DeepFinance for FREE now!

Stay in touch